Commodore Capital’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,800,000
| Closed | -$35.2M | – | 37 |
|
|
2024
Q3 | $35.2M | Buy |
1,800,000
+206,650
| +13% | +$4.04M | 2.2% | 17 |
|
|
2024
Q2 | $32.8M | Buy |
1,593,350
+68,350
| +4% | +$1.41M | 2.24% | 18 |
|
|
2024
Q1 | $32.5M | Buy |
1,525,000
+276,938
| +22% | +$5.91M | 2.18% | 18 |
|
|
2023
Q4 | $17.9M | Sell |
1,248,062
-151,938
| -11% | -$2.18M | 1.57% | 23 |
|
|
2023
Q3 | $12.8M | Hold |
1,400,000
| – | – | 1.49% | 22 |
|
|
2023
Q2 | $14.8M | Buy |
1,400,000
+195,042
| +16% | +$2.06M | 1.66% | 20 |
|
|
2023
Q1 | $14.7M | Buy |
1,204,958
+105,551
| +10% | +$1.29M | 2.24% | 16 |
|
|
2022
Q4 | $13.6M | Buy |
1,099,407
+200,000
| +22% | +$2.48M | 2.06% | 19 |
|
|
2022
Q3 | $12.3M | Sell |
899,407
-927,084
| -51% | -$12.7M | 1.98% | 17 |
|
|
2022
Q2 | $33.5M | Buy |
1,826,491
+1,049,977
| +135% | +$19.2M | 7.08% | 7 |
|
|
2022
Q1 | $12.5M | Buy |
+776,514
| New | +$12.5M | 2.79% | 14 |
|
|
2021
Q4 | – | Sell |
-999,433
| Closed | -$18.7M | – | 29 |
|
|
2021
Q3 | $18.7M | Buy |
999,433
+377,940
| +61% | +$7.08M | 4.94% | 6 |
|
|
2021
Q2 | $13M | Buy |
621,493
+99,938
| +19% | +$2.08M | 4.51% | 8 |
|
|
2021
Q1 | $14.7M | Buy |
521,555
+388,052
| +291% | +$11M | 5.87% | 3 |
|
|
2020
Q4 | $4.36M | Buy |
+133,503
| New | +$4.36M | 2.37% | 19 |
|